Overview of the Therapeutic Potential of Aptamers Targeting Coagulation Factors
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Overview of the Therapeutic Potential of Aptamers Targeting Coagulation Factors
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 8, Pages 3897
Publisher
MDPI AG
Online
2021-04-09
DOI
10.3390/ijms22083897
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The aptamer BT200 blocks von Willebrand factor and platelet function in blood of stroke patients
- (2021) Katarina D. Kovacevic et al. Scientific Reports
- The development and characterization of a long acting anti‐thrombotic von Willebrand factor (VWF) aptamer
- (2020) Shuhao Zhu et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Thrombin binding aptamer G-quadruplex stabilized by pyrene-modified nucleotides
- (2020) Matic Kovačič et al. NUCLEIC ACIDS RESEARCH
- Structure‐Activity Relationship Study of a Potent α‐Thrombin Binding Aptamer Incorporating Hexitol Nucleotides
- (2020) Maria De Fenza et al. CHEMISTRY-A EUROPEAN JOURNAL
- Aptamers, the Nucleic Acid Antibodies, in Cancer Therapy
- (2020) Zhaoying Fu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Potent and rapid reversal of the von Willebrand Factor Inhibitor Aptamer BT200
- (2020) Shuhao Zhu et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Recent Progress in Aptamer Discoveries and Modifications for Therapeutic Applications
- (2020) Shuaijian Ni et al. ACS Applied Materials & Interfaces
- G-quadruplex-based aptamers targeting human thrombin: Discovery, chemical modifications and antithrombotic effects
- (2020) Claudia Riccardi et al. PHARMACOLOGY & THERAPEUTICS
- von Willebrand Factor Predicts Mortality in ACS Patients Treated with Potent P2Y12 Antagonists and is Inhibited by Aptamer BT200 Ex Vivo
- (2020) Katarina D. Kovacevic et al. THROMBOSIS AND HAEMOSTASIS
- Selective Modulation of the Protease Activated Protein C Using Exosite Inhibiting Aptamers
- (2020) Nasim Shahidi Hamedani et al. Nucleic Acid Therapeutics
- Evolution of a highly functional circular DNA aptamer in serum
- (2020) Yu Mao et al. NUCLEIC ACIDS RESEARCH
- Improving Thermodynamic Stability and Anticoagulant Activity of a Thrombin Binding Aptamer by Incorporation of 8-trifluoromethyl-2′-deoxyguanosine
- (2020) Hong-Liang Bao et al. JOURNAL OF MEDICINAL CHEMISTRY
- Cardiovascular therapies utilizing targeted delivery of nanomedicines and aptamers
- (2019) Kei Xian Tan et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Rapidly Neutralizable and High Anticoagulant Thrombin-Binding DNA Aptamer Discovered by Microbeads-Assisted Capillary Electrophoresis (MACE) SELEX
- (2019) Koji Wakui et al. Molecular Therapy-Nucleic Acids
- Comparison of Effects of Anti-thrombin Aptamers HD1 and HD22 on Aggregation of Human Platelets, Thrombin Generation, Fibrin Formation, and Thrombus Formation Under Flow Conditions
- (2019) Katarzyna Derszniak et al. Frontiers in Pharmacology
- Improved RE31 Analogues Containing Modified Nucleic Acid Monomers: Thermodynamic, Structural, and Biological Effects
- (2019) Weronika Kotkowiak et al. JOURNAL OF MEDICINAL CHEMISTRY
- Novel insights into the role of aptamers in the fight against cancer
- (2019) Yasen Maimaitiyiming et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Stability is not everything the case of the cyclization of the thrombin binding aptamer
- (2019) Claudia Riccardi et al. CHEMBIOCHEM
- A structure-activity relationship of a thrombin-binding aptamer containing LNA in novel sites
- (2019) GuoQing Ying et al. BIOORGANIC & MEDICINAL CHEMISTRY
- DNA Nanoscaffold‐Assisted Selection of Femtomolar Bivalent Aptamers for Human α‐Thrombin with Potent Anticoagulant Activity
- (2019) Yu Zhou et al. CHEMBIOCHEM
- Updates on Aptamer Research
- (2019) Ali et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Preclinical Development of a vWF Aptamer to Limit Thrombosis and Engender Arterial Recanalization of Occluded Vessels
- (2019) Shahid M. Nimjee et al. MOLECULAR THERAPY
- Short-Acting Anti-VWF (von Willebrand Factor) Aptamer Improves the Recovery, Survival, and Hemostatic Functions of Refrigerated Platelets
- (2019) Wenchun Chen et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Investigating the properties of TBA variants with twin thrombin binding domains
- (2019) Teresa Amato et al. Scientific Reports
- Aptamers: A Review of Their Chemical Properties and Modifications for Therapeutic Application
- (2019) Adachi et al. MOLECULES
- DNA Aptamers to Thrombin Exosite I. Structure-Function Relationships and Antithrombotic Effects
- (2019) V. A. Spiridonova et al. BIOCHEMISTRY-MOSCOW
- Factor XI(a) inhibitors for thrombosis: an updated patent review (2016-present)
- (2019) Rami A. Al-Horani EXPERT OPINION ON THERAPEUTIC PATENTS
- Novel aptamer to von Willebrand factor A1 domain (TAGX-0004) shows total inhibition of thrombus formation superior to ARC1779 and comparable to caplacizumab
- (2019) Kazuya Sakai et al. HAEMATOLOGICA
- Aptamers Chemistry: Chemical Modifications and Conjugation Strategies
- (2019) Fadwa Odeh et al. MOLECULES
- Methoxymethyl Threofuranosyl Thymidine (4′-MOM-TNA-T) at the T7 Position of the Thrombin-Binding Aptamer Boosts Anticoagulation Activity, Thermal Stability, and Nuclease Resistance
- (2019) Manojkumar Varada et al. ACS Omega
- Inhibition of Tissue Factor Pathway Inhibitor (TFPI) as a Treatment for Haemophilia: Rationale with Focus on Concizumab
- (2018) Pratima Chowdary DRUGS
- A first-in-human study of the safety, tolerability, pharmacokinetics and pharmacodynamics of PF-06741086, an anti-tissue factor pathway inhibitor mAb, in healthy volunteers
- (2018) M. Cardinal et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Combination of aptamer and drug for reversible anticoagulation in cardiopulmonary bypass
- (2018) Ruwan Gunaratne et al. NATURE BIOTECHNOLOGY
- Aptamers in the Therapeutics and Diagnostics Pipelines
- (2018) Harleen Kaur et al. Theranostics
- Thrombin binding aptamer analogues containing inversion of polarity sites endowed with antiproliferative and anti-motility properties against Calu-6 cells
- (2018) Veronica Esposito et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Three decades of nucleic acid aptamer technologies: Lessons learned, progress and opportunities on aptamer development
- (2018) Tao Wang et al. BIOTECHNOLOGY ADVANCES
- Concizumab, an anti-tissue factor pathway inhibitor antibody, induces increased thrombin generation in plasma from haemophilia patients and healthy subjects measured by the thrombin generation assay
- (2017) E. K. Waters et al. HAEMOPHILIA
- Chemical Modifications of Nucleic Acid Aptamers for Therapeutic Purposes
- (2017) Shuaijian Ni et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Generation and characterization of aptamers targeting factor XIa
- (2017) R.S. Woodruff et al. THROMBOSIS RESEARCH
- A Conjugate of Two tPA-Binding RNA Aptamers Efficiently Inhibits Fibrinolysis
- (2017) Nils Bjerregaard et al. Nucleic Acid Therapeutics
- Identification of Aptamers That Bind to Sickle Hemoglobin and Inhibit Its Polymerization
- (2017) Shirley H. Purvis et al. Nucleic Acid Therapeutics
- Selection and characterization of a DNA aptamer inhibiting coagulation factor XIa
- (2017) David A. Donkor et al. Scientific Reports
- Rapid and Label-Free Strategy to Isolate Aptamers for Metal Ions
- (2016) Hao Qu et al. ACS Nano
- Contemporary developments in the discovery of selective factor Xa inhibitors: A review
- (2016) Nirav R. Patel et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Pre-existing anti–polyethylene glycol antibody linked to first-exposure allergic reactions to pegnivacogin, a PEGylated RNA aptamer
- (2016) Nancy J. Ganson et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- High-Affinity DNA Aptamer Generation Targeting von Willebrand Factor A1-Domain by Genetic Alphabet Expansion for Systematic Evolution of Ligands by Exponential Enrichment Using Two Types of Libraries Composed of Five Different Bases
- (2016) Ken-ichiro Matsunaga et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): a randomised clinical trial
- (2016) A Michael Lincoff et al. LANCET
- In Vitro Evaluation of Aptamer-Based Reversible Inhibition of Anticoagulant Activated Protein C as a Novel Supportive Hemostatic Approach
- (2016) Nasim Shahidi Hamedani et al. Nucleic Acid Therapeutics
- Targeting Two Coagulation Cascade Proteases with a Bivalent Aptamer Yields a Potent and Antidote-Controllable Anticoagulant
- (2016) Erin E. Soule et al. Nucleic Acid Therapeutics
- Intracellular Expression of PAI-1 Specific Aptamers Alters Breast Cancer Cell Migration, Invasion and Angiogenesis
- (2016) Yolanda M. Fortenberry et al. PLoS One
- Applications of aptamers for chemistry analysis, medicine and food security
- (2015) Rongrong Huang et al. Science China-Chemistry
- Tissue-type plasminogen activator-binding RNA aptamers inhibiting low-density lipoprotein receptor family-mediated internalisation
- (2015) Kenneth A. Bøtkjær et al. THROMBOSIS AND HAEMOSTASIS
- Particle Display: A Quantitative Screening Method for Generating High-Affinity Aptamers
- (2014) Jinpeng Wang et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Development of Aptamer oligonucleotides as Anticoagulants and Antithrombotics for Cardiovascular Diseases: Current Status
- (2014) Weibin Li et al. THROMBOSIS RESEARCH
- Inhibition of PAI-1 Antiproteolytic Activity Against tPA by RNA Aptamers
- (2014) Jared Damare et al. Nucleic Acid Therapeutics
- Inhibiting the intrinsic pathway of coagulation with a factor XII-targeting RNA aptamer
- (2013) R. S. Woodruff et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Factor XI anion-binding sites are required for productive interactions with polyphosphate
- (2013) Y. Geng et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Aptamer BAX 499 mediates inhibition of tissue factor pathway inhibitor via interaction with multiple domains of the protein
- (2013) E. K. Waters et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Edoxaban versus Warfarin in Patients with Atrial Fibrillation
- (2013) Robert P. Giugliano et al. NEW ENGLAND JOURNAL OF MEDICINE
- ARC15105 Is a Potent Antagonist of Von Willebrand Factor Mediated Platelet Activation and Adhesion
- (2012) Jolanta M. Siller-Matula et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- A Phase 2, randomized, partially blinded, active-controlled study assessing the efficacy and safety of variable anticoagulation reversal using the REG1 system in patients with acute coronary syndromes: results of the RADAR trial
- (2012) Thomas J. Povsic et al. EUROPEAN HEART JOURNAL
- Potent Anticoagulant Aptamer Directed against Factor IXa Blocks Macromolecular Substrate Interaction
- (2012) Bruce Sullenger et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A phase 1 ascending dose study of a subcutaneously administered factor IXa inhibitor and its active control agent
- (2012) J. P. VAVALLE et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Inhibition of tissue factor pathway inhibitor by the aptamer BAX499 improves clotting of hemophilic blood and plasma
- (2012) M. E. GORCZYCA et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- A high affinity, antidote-controllable prothrombin and thrombin-binding RNA aptamer inhibits thrombin generation and thrombin activity
- (2012) K. M. BOMPIANI et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Targeting Tumor Cell Invasion and Dissemination In Vivo by an Aptamer That Inhibits Urokinase-type Plasminogen Activator through a Novel Multifunctional Mechanism
- (2012) K. A. Botkjaer et al. MOLECULAR CANCER RESEARCH
- Direct thrombin inhibitors in cardiovascular disease
- (2012) Kyle A. Arsenault et al. Nature Reviews Cardiology
- Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban for Extended Treatment of Venous Thromboembolism
- (2012) Giancarlo Agnelli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Initial experience from a double-blind, placebo-controlled, clinical outcome study of ARC1779 in patients with thrombotic thrombocytopenic purpura
- (2011) Spero R. Cataland et al. AMERICAN JOURNAL OF HEMATOLOGY
- Aptamer ARC19499 mediates a procoagulant hemostatic effect by inhibiting tissue factor pathway inhibitor
- (2011) E. K. Waters et al. BLOOD
- Characteristics of a New DNA Aptamer, Direct Inhibitor of Thrombin
- (2011) A. V. Mazurov et al. BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE
- Aptamers as Therapeutics in Cardiovascular Diseases
- (2011) P. Wang et al. CURRENT MEDICINAL CHEMISTRY
- Direct Thrombin Inhibitors
- (2011) P. Joshua O’Brien et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- Improvement of spatial fibrin formation by the anti-TFPI aptamer BAX499: changing clot size by targeting extrinsic pathway initiation
- (2011) L. A. PARUNOV et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Probing the Limits of Aptamer Affinity with a Microfluidic SELEX Platform
- (2011) Kareem M. Ahmad et al. PLoS One
- The von Willebrand Inhibitor ARC1779 Reduces Cerebral Embolization After Carotid Endarterectomy
- (2011) Hugh S. Markus et al. STROKE
- A dose ranging phase I/II trial of the von Willebrand factor inhibiting aptamer ARC1779 in patients with congenital thrombotic thrombo - cytopenic purpura
- (2011) Petra Jilma-Stohlawetz et al. THROMBOSIS AND HAEMOSTASIS
- Effects of Plasminogen Activator Inhibitor-1–Specific RNA Aptamers on Cell Adhesion, Motility, and Tube Formation
- (2011) Stephanie Brandal et al. Nucleic Acid Therapeutics
- RNA Aptamers as Conformational Probes and Regulatory Agents for Plasminogen Activator Inhibitor-1
- (2010) Jeppe B. Madsen et al. BIOCHEMISTRY
- An Anti-von Willebrand Factor Aptamer Reduces Platelet Adhesion Among Patients Receiving Aspirin and Clopidogrel in an Ex Vivo Shear-Induced Arterial Thrombosis
- (2010) Dabit Arzamendi et al. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
- Oral Rivaroxaban for Symptomatic Venous Thromboembolism
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Serum-stable RNA aptamers to urokinase-type plasminogen activator blocking receptor binding
- (2010) D. M. Dupont et al. RNA
- A randomised pilot trial of the anti-von Willebrand factor aptamer ARC1779 in patients with type 2b von Willebrand disease
- (2010) Petra Paulinska et al. THROMBOSIS AND HAEMOSTASIS
- Translating Nucleic Acid Aptamers to Antithrombotic Drugs in Cardiovascular Medicine
- (2010) Thomas J. Povsic et al. Journal of Cardiovascular Translational Research
- The Chemical Biology of Aptamers
- (2009) Günter Mayer ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Inhibition of Thrombin Activity with DNA-Aptamers
- (2009) A. B. Dobrovolsky et al. BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE
- An Exosite-Specific ssDNA Aptamer Inhibits the Anticoagulant Functions of Activated Protein C and Enhances Inhibition by Protein C Inhibitor
- (2009) Jens Müller et al. CHEMISTRY & BIOLOGY
- An Anticoagulant RNA Aptamer That Inhibits Proteinase-Cofactor Interactions within Prothrombinase
- (2009) Sai K. Buddai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of von Willebrand factor-mediated platelet activation and thrombosis by the anti-von Willebrand factor A1-domain aptamer ARC1779
- (2009) J. L. DIENER et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Antimetastatic Potential of PAI-1–Specific RNA Aptamers
- (2009) Charlene M. Blake et al. OLIGONUCLEOTIDES
- The aptamer ARC1779 is a potent and specific inhibitor of von willebrand factor mediatedex vivoplatelet function in acute myocardial infarction
- (2009) Alexander O. Spiel et al. PLATELETS
- Synergistic effect of aptamers that inhibit exosites 1 and 2 on thrombin
- (2009) S. M. Nimjee et al. RNA
- Identification of Liver Cancer-Specific Aptamers Using Whole Live Cells
- (2008) Dihua Shangguan et al. ANALYTICAL CHEMISTRY
- Molecular Recognition of Small-Cell Lung Cancer Cells Using Aptamers
- (2008) Hui William Chen et al. ChemMedChem
- Anticoagulant characteristics of HD1-22, a bivalent aptamer that specifically inhibits thrombin and prothrombinase
- (2008) J. MÜLLER et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- A randomized, repeat-dose, pharmacodynamic and safety study of an antidote-controlled factor IXa inhibitor
- (2008) M. Y. CHAN et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started